21053 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors from plants
Methods and Compositions for Treating Diabetes
#2METHODS AND COMPOSITIONS FOR REDUCING BODY WEIGHT IN MAMMALS
#3Methods and Compositions for Oral Administration of Proteins
#4METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION
#5GIP/GLP1 CO-AGONIST COMPOUNDS
#6GIP/GLP1 CO-AGONIST COMPOUNDS
#7Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
#8Methods and Compositions for Treating Diabetes
#9Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
#10METHODS AND COMPOSITIONS FOR TREATING DIABETES
#11METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#12Methods and compositions for oral administration
#13GIP/GLP1 co-agonist compounds
#14Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
#15Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
#16Methods and Compositions for Oral Administration of Exenatide
#17Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof
#18Methods and compositions for oral administration of proteins
#19Methods and compositions for treating diabetes
#20GIP/GLP1 co-agonist compounds
#21Methods and compositions for oral administration
#22Methods and Compositions for Treating Diabetes
#23Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
#24Methods and Compositions for Rectal Administration of Exenatide
#25Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
#26METHODS FOR PRODUCING PEPTIDES AND USES THEREOF
#27PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, PROCESS FOR ITS PREPARATION, AND ITS USE
#28Methods and compositions for oral administration of proteins
#29Methods and compositions for oral administration
#30WHEAT BRAN SOLUBLE EXTRACT AS ANTI-BIOFILM AGENT
#31METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#32INFANT NUTRITION WITH PROTEASE INHIBITOR
#33Novel Oral Pharmaceutical Composition for Treatment of Diabetes
#34Methods and compositions for oral administration
#35ORAL DELIVERY OF PROTEINS AND PEPTIDES
#36METHODS AND COMPOSITIONS FOR TREATING NAFLD, HEPATIC STEATOSIS, AND SEQUELAE THEREOF
#37Methods and compositions for treating diabetes
#38TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#39Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
#40Methods of delivering stable topical drug compositions
#41Methods of delivering stable topical drug compositions
#42Anti-pathogen systems
#43Methods and compositions for oral administration of exenatide
#44Natural plant products for control of cancer metastasis
#45INFANT NUTRITION WITH PROTEASE INHIBITOR
#46PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION
#47Plant Extracts and Dermatological Uses Thereof
#48Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
#49Methods and compositions for oral administration of insulin
#50Topical drug delivery using phosphatidylcholine
#51Method Of Delivering Stable Topical Drug Compositions
#52METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE
#53Methods and compositions for oral administration of proteins
#54Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
#55ORAL DELIVERY OF PROTEINS AND PEPTIDES
#56TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#57METHODS OF DIAGNOSING, TREATING, AND PREVENTING INCREASED VASCULAR PERMEABILITY
#58Use of microproteins as tryptase inhibitors
#59Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
#60Infant Nutrition With Protease Inhibitor
#61Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
#62Plant extracts and dermatological uses thereof
#63Methods and compositions for oral administration of proteins
#64Stable topical drug delivery compositions
#65Potato proteinase inhibitor II exhibits activity in elevating fasting plasma cholecystokinin concentrations
#66Methods of delivering stable topical drug compositions
#67Topical drug delivery using phosphatidylcholine
#68Compositions and methods for the treatment or prevention of gallbladder disease
#69Control of canine voluntary food intake
#70Non-catalytic combustor for reducing NOx emissions
#71Phaseolamin compositions and methods for using the same
#72Preparation and method for weight reduction
#73Compositions comprising pemvidutide and an acylated amino acid